These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 25754609)

  • 1. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.
    Berbée JF; Boon MR; Khedoe PP; Bartelt A; Schlein C; Worthmann A; Kooijman S; Hoeke G; Mol IM; John C; Jung C; Vazirpanah N; Brouwers LP; Gordts PL; Esko JD; Hiemstra PS; Havekes LM; Scheja L; Heeren J; Rensen PC
    Nat Commun; 2015 Mar; 6():6356. PubMed ID: 25754609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.
    Hoeke G; Wang Y; van Dam AD; Mol IM; Gart E; Klop HG; van den Berg SM; Pieterman EH; Princen HMG; Groen AK; Rensen PCN; Berbée JFP; Boon MR
    Atherosclerosis; 2017 Dec; 267():116-126. PubMed ID: 29121499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirabegron-induced brown fat activation does not exacerbate atherosclerosis in mice with a functional hepatic ApoE-LDLR pathway.
    Ying Z; van Eenige R; Beerepoot R; Boon MR; Kloosterhuis NJ; van de Sluis B; Bartelt A; Rensen PCN; Kooijman S
    Pharmacol Res; 2023 Jan; 187():106634. PubMed ID: 36574856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.
    Liu C; Schönke M; Zhou E; Li Z; Kooijman S; Boon MR; Larsson M; Wallenius K; Dekker N; Barlind L; Peng XR; Wang Y; Rensen PCN
    Cardiovasc Res; 2022 Jan; 118(2):489-502. PubMed ID: 33693480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidaemia: Active BAT reduces atherosclerosis.
    Geach T
    Nat Rev Endocrinol; 2015 Jun; 11(6):317. PubMed ID: 25824681
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of Brown Fat in Lipoprotein Metabolism and Atherosclerosis.
    Hoeke G; Kooijman S; Boon MR; Rensen PC; Berbée JF
    Circ Res; 2016 Jan; 118(1):173-82. PubMed ID: 26837747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development.
    Zhou E; Hoeke G; Li Z; Eibergen AC; Schonk AW; Koehorst M; Boverhof R; Havinga R; Kuipers F; Coskun T; Boon MR; Groen AK; Rensen PCN; Berbée JFP; Wang Y
    Cardiovasc Res; 2020 Aug; 116(10):1710-1720. PubMed ID: 31589318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary choline increases brown adipose tissue activation markers and improves cholesterol metabolism in female APOE*3-Leiden.CETP mice.
    Liu C; Song Z; Li Z; Boon MR; Schönke M; Rensen PCN; Wang Y
    Int J Obes (Lond); 2023 Mar; 47(3):236-243. PubMed ID: 36732416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of brown fat activation on top of PCSK9 inhibition with alirocumab on dyslipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice.
    Zhou E; Li Z; Nakashima H; Choukoud A; Kooijman S; Berbée JFP; Rensen PCN; Wang Y
    Pharmacol Res; 2021 May; 167():105524. PubMed ID: 33667684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans.
    Ying Z; Tramper N; Zhou E; Boon MR; Rensen PCN; Kooijman S
    Cardiovasc Res; 2023 May; 119(4):905-918. PubMed ID: 35944189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic receptor-mediated activation of FGF-21-adiponectin axis exerts atheroprotective effects in brown adipose tissue-transplanted apoE
    Kikai M; Yamada H; Wakana N; Terada K; Yamamoto K; Wada N; Motoyama S; Saburi M; Sugimoto T; Irie D; Kato T; Kawahito H; Ogata T; Matoba S
    Biochem Biophys Res Commun; 2018 Mar; 497(4):1097-1103. PubMed ID: 29496444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice.
    Ryu SK; King TJ; Fujioka K; Pattison J; Pashkow FJ; Tsimikas S
    Atherosclerosis; 2012 May; 222(1):99-105. PubMed ID: 22406426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice.
    Geerling JJ; Boon MR; van der Zon GC; van den Berg SA; van den Hoek AM; Lombès M; Princen HM; Havekes LM; Rensen PC; Guigas B
    Diabetes; 2014 Mar; 63(3):880-91. PubMed ID: 24270984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged daily light exposure increases body fat mass through attenuation of brown adipose tissue activity.
    Kooijman S; van den Berg R; Ramkisoensing A; Boon MR; Kuipers EN; Loef M; Zonneveld TC; Lucassen EA; Sips HC; Chatzispyrou IA; Houtkooper RH; Meijer JH; Coomans CP; Biermasz NR; Rensen PC
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6748-53. PubMed ID: 25964318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Brown Fat Lipoatrophy Aggravates Atherosclerotic Process in Male Mice.
    Gómez-Hernández A; Beneit N; Escribano Ó; Díaz-Castroverde S; García-Gómez G; Fernández S; Benito M
    Endocrinology; 2016 Sep; 157(9):3517-28. PubMed ID: 27414981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USF1 deficiency activates brown adipose tissue and improves cardiometabolic health.
    Laurila PP; Soronen J; Kooijman S; Forsström S; Boon MR; Surakka I; Kaiharju E; Coomans CP; Van Den Berg SA; Autio A; Sarin AP; Kettunen J; Tikkanen E; Manninen T; Metso J; Silvennoinen R; Merikanto K; Ruuth M; Perttilä J; Mäkelä A; Isomi A; Tuomainen AM; Tikka A; Ramadan UA; Seppälä I; Lehtimäki T; Eriksson J; Havulinna A; Jula A; Karhunen PJ; Salomaa V; Perola M; Ehnholm C; Lee-Rueckert M; Van Eck M; Roivainen A; Taskinen MR; Peltonen L; Mervaala E; Jalanko A; Hohtola E; Olkkonen VM; Ripatti S; Kovanen PT; Rensen PC; Suomalainen A; Jauhiainen M
    Sci Transl Med; 2016 Jan; 8(323):323ra13. PubMed ID: 26819196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Pharmacological Thermogenic Adipocyte Activation on Metabolism and Atherosclerotic Plaque Regression.
    Worthmann A; Schlein C; Berbée JFP; Rensen PCN; Heeren J; Bartelt A
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30813320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish oil intake induces UCP1 upregulation in brown and white adipose tissue via the sympathetic nervous system.
    Kim M; Goto T; Yu R; Uchida K; Tominaga M; Kano Y; Takahashi N; Kawada T
    Sci Rep; 2015 Dec; 5():18013. PubMed ID: 26673120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brown adipose tissue activity controls triglyceride clearance.
    Bartelt A; Bruns OT; Reimer R; Hohenberg H; Ittrich H; Peldschus K; Kaul MG; Tromsdorf UI; Weller H; Waurisch C; Eychmüller A; Gordts PL; Rinninger F; Bruegelmann K; Freund B; Nielsen P; Merkel M; Heeren J
    Nat Med; 2011 Feb; 17(2):200-5. PubMed ID: 21258337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging attenuates diurnal lipid uptake by brown adipose tissue.
    In Het Panhuis W; Schönke M; Siebeler R; Afkir S; Baelde R; Pronk ACM; Streefland TCM; Sips HCM; Lalai RA; Rensen PCN; Kooijman S
    Aging (Albany NY); 2022 Oct; 14(19):7734-7751. PubMed ID: 36202134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.